Journal
/
Médecine
/
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Journal JoVE
Médecine
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Médecine
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Please note that all translations are automatically generated. Click here for the English version.

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

DOI:

•

07:24 min

•

December 28, 2016

•

, , , ,
1BioMedomics Inc., 2Division of Hematology, Department of Medicine,Duke University Medical Center

Chapitres

  • 00:05Titre
  • 01:22Preparation for Testing
  • 02:15Lot Verification Procedure
  • 03:05Blood Sample Collection
  • 04:14Testing Procedure
  • 05:06Results: Lateral Flow Immunoassay Ensures Precise Hemoglobin S Measurements
  • 05:48Conclusion

Summary

Traduction automatique

Traduction automatique

We have developed a point-of-care immunoassay to rapidly quantify hemoglobin S (HbS) levels during transfusion therapy for sickle cell disease (SCD) patients. By applying a small amount of treated blood to the device, the healthcare provider can determine the %HbS in a SCD patient to immediately inform clinical decisions.

Tags

MédecineSickle cell diseasepoint-of-carelateral flow immunoassayrapid testtransfusionprecision medicinehemoglobin SHbSnear-patienthemoglobinopathy

Article

Embed

AJOUTER À LA PLAYLIST

Usage Statistics

Vidéos Connexes

Read Article